Countagen is a Stockholm-based biotechnology company comited to accelerate the pace of gene editing advancements by providing high-resolution gene editing characterization.

Out technology platform, LockSeq, is a novel targeted NGS library preparation based on a unique gap-fill chemistry that minimizes target dropouts and amplification bias, enabling routine and standardized gene editing characterization at every stage of development.

The LockSeq Advantage:
- Simultaneous Indel Profiling: Profile and validate hundreds of genomic loci in a single reaction.
- High Sensitivity: Robust detection of on- and off-target edits down to 0.1% frequency.
- Broad Compatibility: Compatibility across sequencing platforms.
- Cost-Efficient Scalability: Scale panels and samples with minimal target dropout and uniform target capture.

📍 Based in the SciLifeLab / Karolinska Institutet ecosystem, Solna.

Countagen

Felix Neumann

This department focuses on scientific exploration and application development to drive innovation.

Countagen

Org chart

Teams

Research and Development

Offices

Countagen

Org chart

Teams

Research and Development

Offices

Related companies